SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

RaveDAO is a global community uniting music, technology, and purpose. Since their first sold-out event at Dubai 2024, they have expanded across Europe, the Middle East, North America, and Asia, hosting world-class experiences with over 100,000 total attendees and 3,000+ attendees for each event.  RaveDAO has worked with top-tier artists like Vintage Culture, Don Diablo, Chris Avantgarde, Lilly Palmer, MORTEN, Bassjackers, and GENESI and has support from Binance, OKX, Bitget, and Polygon. RaveDAO is redefining live entertainment in Web3 and has active partnerships with 1001Tracklists, AMF, and Warner Music.  Beyond the dance floor, RaveDAO channels energy and attention toward impact. In 2025 alone, proceeds from its events helped restore sight to 400+ cataract patients in Nepal and fund over 150 meditation programs across the U.S.

RaveDAO

RaveDAO is seeing massive volatility and intense community debate as the token experiences a parabolic rally, with supporters highlighting global event partnerships and DAO expansion while critics raise significant alarms regarding extreme wallet concentration and potential market manipulation. The conversation is currently dominated by those comparing the rapid price action to historical pump-and-dump cycles, while others remain focused on upcoming event catalysts as a justification for further upside.

NANO Nuclear Energy, Inc. is a microreactor and nuclear technology company, which provides supply energy services. Its products in technical development are ZEUS, a solid core battery reactor, and ODIN, a low-pressure coolant reactor. The company is founded by Jiang Yu in February, 2022 and is headquartered in New York, NY.

Nano Nuclear Energy Inc.

Nano Nuclear Energy is trending as investors weigh its potential in the emerging small modular reactor market against broader sector volatility. Community discussion is heavily focused on the company's technical development milestones, partnerships for reactor deployment, and the ongoing debate regarding the valuation of pre-revenue nuclear firms compared to their long-term growth narrative.

Terrestrial Energy, Inc. is an advanced nuclear technology company focused on next-generation nuclear energy systems. The company is developing the Integral Molten Salt Reactor (IMSR), an innovative type of Generation IV molten salt reactor designed to produce reliable, low-carbon heat and electricity at competitive costs. The company is headquartered in Charlotte, NC.

Terrestrial Energy Inc.

IMSR is experiencing significant market interest driven by news of its TEFLA and TETRA reactor pilot projects and ongoing NRC regulatory engagement for molten salt reactor tech. Community discussions are centered on the stock's potential to scale alongside data center energy demands, with active debates regarding its long-term deployment timeline, insider compensation, and comparative valuation against other nuclear sector players.

NuScale Power Corp. provides proprietary and innovative advanced small modular reactor (SMR) nuclear technology, with a mission to help power the global energy transition by delivering safe, scalable, and reliable carbon-free energy. Its products include VOYGR SMR Plants and Energy Exploration (E2) Centers. The company was founded by José N. Reyes in 2007 and is headquartered in Corvallis, OR.

NuScale Power Corporation - Ordinary Shares - Class A

NuScale Power Corp

NuScale Power is garnering significant attention as investors react to a federal directive accelerating nuclear energy development for space, lunar, and defense infrastructure, with the community actively debating the company's long-term utility versus its recent performance. While some traders are focused on potential short-squeeze dynamics and the impact of institutional selling, others are fixated on the evolving role of small modular reactors in meeting the massive electricity demands of AI data centers.

Compass Pathways Plc is a biotechnology company, which provides mental health care services. It focuses on improving the lives of those who are suffering with mental health challenges and who are not helped by current treatments. The company was founded by Goldsmith George Jay and Malievskaia Ekaterina in 2016 and is headquartered in London, the United Kingdom.

Compass Pathways Plc - ADR

COMPASS Pathways

COMPASS Pathways is trending as market sentiment shifts following a high-profile executive order to accelerate FDA review timelines for psychedelic-assisted therapies, positioning the firm as a leader in the treatment-resistant depression space. Investors are aggressively discussing the potential for rapid clinical expansion and the significant opportunity as the company approaches critical Phase 3 trial readouts in the coming months.

TokenOS is the world’s most advanced AI-powered Web3 development platform, designed to turn natural language prompts into fully functional, production-ready blockchain applications. From simple tokens and memecoins to complex DeFi protocols, TokenOS automates the creation, deployment, and auditing of smart contracts and dApps with enterprise-grade reliability. By combining advanced language models with blockchain infrastructure, TokenOS removes the barriers of technical expertise, making Web3 development accessible to everyone. With instant deployment, built-in security best practices, and cross-chain support on the roadmap, TokenOS empowers entrepreneurs, developers, and creators to launch tokenized businesses and decentralized applications in seconds.

TokenOS AI

TokenOS AI is gaining community traction as investors highlight its potential as an under-the-radar AI utility play compared to larger established projects in the sector. Discussion centers on the project's long-term growth prospects and its role as a micro-cap opportunity within the AI and web3 landscape.

Aave is a decentralized money market protocol where users can lend and borrow cryptocurrency across 20 different assets as collateral. The protocol has a native token called AAVE, which is also a governance token that lets the community decide the direction of the protocol in a collective manner. Lenders can&nbsp;earn interest by providing liquidity to the market, while borrowers can borrow by collateralizing their cryptoassets to take out loans from the liquidity pools.

AAVE

AAVE is currently trending as investors debate its potential for a breakout, driven by active community discussions surrounding bullish technical setups, fee-generation utility, and its positioning within the broader DeFi sector. While some retail traders are focused on short-term price action and bear trap theories, others are highlighting the project's long-term value accrual, institutional adoption, and recent roadmap developments as catalysts for future growth.

Highstreet

Highstreet is seeing intense community speculation as investors debate whether the token is poised for a major short squeeze or a continued downward trend. Traders are actively comparing it to previous volatile runners and monitoring whale wallet activity to justify their positions while discussing the risks of price manipulation.

Investment Managers Series Trust II - Tradr 2X Long ASTS Daily ETF

Tradr 2X Long ASTS Daily ETF

Traders are actively using the 2X leveraged ETF to amplify exposure to AST SpaceMobile, debating its high-volatility nature and potential for rapid momentum-driven gains. While some community members view it as an essential tool for capturing breakouts, others caution against the structural risks and decay associated with daily leveraged products.

Cameco Corp. engages in the provision of uranium. It operates through the Uranium and Fuel Services segments. The Uranium segment is involved in the exploration for, mining, milling, purchase, and sale of uranium concentrate. The Fuel Services segment deals with the refining, conversion, and fabrication of uranium concentrate and the purchase and sale of conversion services. The company was founded in 1988 and is headquartered in Saskatoon, Canada.

Cameco Corp.

Cameco is surging as part of a major strategic partnership involving Brookfield and the U.S. government to invest billions in expanding nuclear reactor infrastructure to meet data center energy demand. The community is actively discussing the stock's role as a long-term 'picks and shovels' play for the AI energy revolution, with many traders focused on the technical breakout and potential for increased institutional and government support.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Delcath Systems (NASDAQ:DCTH) Stock Price Up 0.3% - Time to Buy?

Delcath Systems (NASDAQ:DCTH) Shares Up 0.3% - Should You Buy...

Implied Volatility Surging for Delcath Systems Stock Options

Investors need to pay close attention to DCTH stock based on the movements in the options market lately.

Delcath Systems, Inc. Announces Inclusion of CHEMOSAT Hepatic Delivery System for Melphalan as a Recommended Liver-Directed Regional Therapy Option in the ESMOEURACAN Clinical Practice Guidelines for Uveal Melanoma

Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on liver-directed cancer therapies, today announced that its proprietary CHEMOSAT Hepatic Delivery System for...

Delcath Systems to Participate at the Society of Interventional Radiology 2026 Meeting

Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, will attend the Society of Interventional Radiology...

Delcath Systems, Inc. (NASDAQ:DCTH) Given Average Rating of "Moderate Buy" by Brokerages

Shares of Delcath Systems, Inc. (NASDAQ:DCTH - Get Free Report) have earned an average recommendation of "Moderate Buy" from the six ratings firms that are currently covering the stock, Marketbeat reports. One investment analyst has rated the stock with a sell rating and five have issued a buy ra...

Divisadero Street Capital Management LP Invests $5.12 Million in Delcath Systems, Inc. $DCTH

Divisadero Street Capital Management LP purchased a new position in Delcath Systems, Inc. (NASDAQ:DCTH - Free Report) in the 3rd quarter, according to the company in its most recent disclosure with...

Propel Bio Management LLC Buys 212,457 Shares of Delcath Systems, Inc. $DCTH

Propel Bio Management LLC grew its stake in shares of Delcath Systems, Inc. (NASDAQ:DCTH - Free Report) by 94.0% during the third quarter, according to its most recent filing with the Securities and...

Delcath Systems Announces Publication of CHOPIN Clinical Trial Results in The Lancet Oncology

Delcath Systems, Inc. (Nasdaq: DCTH), (Delcath or the Company) an interventional oncology company focused on the treatment of primary and metastatic liver cancers, today announced the publication of...

FY2029 EPS Forecast for Delcath Systems Decreased by Analyst

Delcath Systems, Inc. (NASDAQ:DCTH - Free Report) - Equities researchers at HC Wainwright dropped their FY2029 EPS estimates for shares of Delcath Systems in a note issued to investors on Monday...

Delcath Systems, Inc. (NASDAQ:DCTH) Given Consensus Recommendation of "Moderate Buy" by Brokerages

Shares of Delcath Systems, Inc. (NASDAQ:DCTH - Get Free Report) have been assigned an average rating of "Moderate Buy" from the six research firms that are currently covering the company, MarketBeat...

Delcath Systems, Inc. is an oncology company, which engages in the treatment of primary and metastatic liver cancers. Its products include CHEMOSAT and HEPZATO. The company was founded on August 5, 1988 and is headquartered in Queensbury, NY.

Current Price	$10.86
Prev Close	$10.83
Open	$11.05
Dividend Yield	0.00%
50-Day Moving Average	$9.55
Beta	1.25
Avg. Volume	388,445.07
PE Ratio	173.21

52-Week High	$18.23
52-Week Low	$8.12
Market Capitalization	$377.34M
EPS (Annual)	$0.0676
Price to Book	3.39
Revenue Per Employee	$546,352.56

DCTH
Delcath Systems Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest DCTH News

DCTHDelcath Systems Inc